Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extraosseous Ewing Sarcoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Very early researchStudy completedNCT01825902
What this trial is testing

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

Who this might be right for
Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)Ewing Sarcoma of BoneExtraosseous Ewing Sarcoma+3 more
Mayo Clinic 1
Testing effectiveness (Phase 2)Study completedNCT00003745
What this trial is testing

Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 125
Testing effectiveness (Phase 2)Study completedNCT00516295
What this trial is testing

Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

Who this might be right for
Ewing Sarcoma of BoneExtraosseous Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor+1 more
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)Study completedNCT01231906
What this trial is testing

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Who this might be right for
Localized Extraskeletal Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor of BonePeripheral Primitive Neuroectodermal Tumor of Soft Tissues
Children's Oncology Group 642
Testing effectiveness (Phase 2)Study completedNCT00003667
What this trial is testing

Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Not applicableWithdrawnNCT01795430
What this trial is testing

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

Who this might be right for
Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)Ewing Sarcoma of BoneExtraosseous Ewing Sarcoma+4 more
City of Hope Medical Center
Not applicableNot Yet RecruitingNCT06526897
What this trial is testing

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

Who this might be right for
Adult Pleomorphic RhabdomyosarcomaAJCC Grade 2 SarcomaAJCC Grade 3 Sarcoma+20 more
ECOG-ACRIN Cancer Research Group 1,582
Large-scale testing (Phase 3)Study completedNCT00876031
What this trial is testing

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University Hospital Tuebingen 195
Testing effectiveness (Phase 2)Study completedNCT00025441
What this trial is testing

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
Societe Internationale d'Oncologie Pediatrique
Testing effectiveness (Phase 2)Study completedNCT01222767
What this trial is testing

Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy

Who this might be right for
Ewing's SarcomaPrimitive Neuroectodermal Tumor (PNET)Askin's Tumor of the Chest Wall+1 more
PharmaMar 17